NewAmsterdam Pharma Announces Appointment of Ian Somaiya as Chief Financial Officer
Position
Chief Financial Officer
Company
NewAmsterdam Pharma
NetherlandsBiotechnologyHealth CareTherapeuticsDescription
NAARDEN, the Netherlands and MIAMI, Oct. 23, 2023 -- NewAmsterdam Pharma Company N.V. , a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol , for whom existing therapies are not sufficiently effective or well-tolerated, today announced the appointment of Ian Somaiya as Chief Financial Officer
Quick answer
NewAmsterdam Pharma Announces Appointment of Ian Somaiya as Chief Financial Officer (October 23, 2023). NewAmsterdam Pharma is based in Netherlands.
- Who is the new Chief Financial Officer at NewAmsterdam Pharma?
- NewAmsterdam Pharma named Ian Somaiya Chief Financial Officer, announced October 23, 2023.
- What did NewAmsterdam Pharma announce on October 23, 2023?
- NAARDEN, the Netherlands and MIAMI, Oct. 23, 2023 -- NewAmsterdam Pharma Company N.V. , a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol , for whom existing therapies are not sufficiently effective or well-tolerated, today announced the appointment of Ian Somaiya as Chief...
- What does NewAmsterdam Pharma do?
- Founded in 2019, NewAmsterdam Pharma is a late-stage clinical biopharmaceutical company focused on the research and development of transformative therapies for cardiometabolic diseases.
- Where is NewAmsterdam Pharma based?
- NewAmsterdam Pharma is based in Netherlands.
- Which similar companies made leadership changes around the same time?
- Dimerix Limited (October 23, 2023), Tevogen Inc. (October 23, 2023), mbiomics (October 24, 2023) and Theragent (October 24, 2023) also announced leadership changes within 45 days of NewAmsterdam Pharma.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Dimerix Limited Announces Appointment of Dr David Fuller as Chief Medical Officer (October 23, 2023)
- Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative (October 23, 2023)
- mbiomics Appoints Seasoned Microbiome Expert Christopher Weidenmaier as Chief Scientific Officer (October 24, 2023)
- Theragent Welcomes Seasoned Cell Therapy Professional Brian Newsom as New Vice President of Business Development (October 24, 2023)
- Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery (October 24, 2023)
- Q32 Bio Appoints Saul Fink, Ph.D. as Chief Technology Officer (October 24, 2023)
Who to call at NewAmsterdam Pharma, and when
A new leader at NewAmsterdam Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day NewAmsterdam Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NewAmsterdam Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NewAmsterdam Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NewAmsterdam Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NewAmsterdam Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.